Exceeding Launch Targets by 300%

amag

featured case study

Reinventing Commercial Strategy in Women’s Health: From Launch to Turnaround in Record Time

At AMAG Pharmaceuticals, Meghan brought bold thinking to the forefront—and led her team in delivering transformative results. Tasked with launching a first-in-class product in a nascent category, she guided the team in redefining what modern pharma commercialization could look like.

Together, they executed an unconventional brand strategy, a disruptive go-to-market model, and a forward-thinking access and pricing plan. The result? A launch that shattered expectations—exceeding forecast by 300% in the very first quarter.

But Meghan’s impact didn’t stop there. When faced with a declining in-market product and significant operational budget cuts, she led her team through a swift and strategic pivot. 

In under six months, they executed a turnaround that surpassed demand forecasts for the first time, restored profitability, and stabilized field sales operations.

Under Meghan’s leadership, the team also built first-of-their-kind capabilities in pharma—introducing virtual medicine support, AI-powered chatbots, and scalable digital tools that served the entire portfolio. Additionally, she oversaw the integration of a consumer business unit (Cord Blood Registry), returning it to growth in just two quarters.

This case highlights the power of progressive leadership, agile thinking, and commercial innovation—especially in one of the most complex categories in healthcare.